The Nuclear Control of Cell Growth and Differentiation (NC) Program is a laboratory-based, basic science program focused on the genetic basis of cancer with collaborative connections to all other programs within Huntsman Cancer Institute. The research goal is to investigate fundamental mechanisms in the nucleus that go awry in the cancer cell that may be exploited to impact new approaches to cancer prevention, diagnostics, prognostics, and treatment. Areas of particular emphasis include maintenance of genome stability, including DNA damage and repair;epigenetic involving DNA methylation and chromatin dynamics;transcripfional regulation of gene expression through sequence-specific DNA binding proteins, including ones implicated in human cancer;and analysis of transcriptional networks that drive embryonic development, organogenesis, and cell metabolism. The NC Program has depth and strength in all major experimental approaches, including basic chemistry and biochemistry;structural biology;molecular, cell, and cancer biology;genetic and genomic approaches;and the use of animal systems for discovery and validation of cancer pathways in humans. Major achievements over the last five years include discovery of a DNA demethylase that directs epigenetic programming and is associated with cancer progression, elucidation of critical downstream targets of oncogenic transcription factors in the ETS family in the context of sarcoma and prostate cancer, and creation of mouse models of sarcoma through pioneering gene targeting technologies. Led by Barbara Graves, PhD, and Stephen Lessnick, MD, PhD, the Program has 23 members from nine departments and two colleges. There are three HHMI Investigators. As of December 2008, NC members had $9.8M in peer-reviewed annual direct costs for research projects, including 11% from NCI. Since July 2003, their research has been reported in 220 publications, of which 9% were intra- and 14% were interprogrammatic collaborations. Six new members are MD/PhDs, including the Co-Leader, and bring a clinical perspective to the Program. More than 90% of members have peer-reviewed funding and several members have highly distinguished awards, including the Nobel Prize in Medicine or Physiology, awarded to Mario Capecchi, PhD, for his pioneering work in gene targeting in 2007. The Cancer Center enhances the research goals and integration of this Program through fostering collaborative and transdisciplinary interactions as well as providing access to shared resources, NC programmatic funds, and support for faculty recruitments. In the next five years, the NC Program will continue initiatives to elucidate basic cancer mechanisms and to educate both Center members, as well as the next generation of cancer researchers, with the ultimate goal of impacting the care of cancer patients within an individualized oncology paradigm.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA042014-24
Application #
8465109
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-05-01
Budget End
2014-04-30
Support Year
24
Fiscal Year
2013
Total Cost
$41,476
Indirect Cost
$21,836
Name
University of Utah
Department
Type
DUNS #
009095365
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Fuller, Andrew K; Bice, Benjamin D; Venancio, Ashlee R et al. (2018) A Method to Define the Effects of Environmental Enrichment on Colon Microbiome Biodiversity in a Mouse Colon Tumor Model. J Vis Exp :
Wang, Sophia S; Carrington, Mary; Berndt, Sonja I et al. (2018) HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes. Cancer Res 78:4086-4096
Faham, Najme; Zhao, Ling; Welm, Alana L (2018) mTORC1 is a key mediator of RON-dependent breast cancer metastasis with therapeutic potential. NPJ Breast Cancer 4:36
Rengifo-Cam, William; Shepherd, Hailey M; Jasperson, Kory W et al. (2018) Colon Pathology Characteristics in Li-Fraumeni Syndrome. Clin Gastroenterol Hepatol 16:140-141
Solomon, Benjamin L; Garrido-Laguna, Ignacio (2018) Upper gastrointestinal malignancies in 2017: current perspectives and future approaches. Future Oncol 14:947-962
Gaffney, David K; Hashibe, Mia; Kepka, Deanna et al. (2018) Too many women are dying from cervix cancer: Problems and solutions. Gynecol Oncol 151:547-554
Hardy, Christopher M; Burke, Molly K; Everett, Logan J et al. (2018) Genome-Wide Analysis of Starvation-Selected Drosophila melanogaster-A Genetic Model of Obesity. Mol Biol Evol 35:50-65
Gilcrease, Eddie B; Casjens, Sherwood R (2018) The genome sequence of Escherichia coli tailed phage D6 and the diversity of Enterobacteriales circular plasmid prophages. Virology 515:203-214
Park, Jihye; Blackburn, Brenna E; Rowe, Kerry et al. (2018) Rural-metropolitan disparities in ovarian cancer survival: a statewide population-based study. Ann Epidemiol 28:377-384
Fowler, Brynn; Ding, Qian; Pappas, Lisa et al. (2018) Utah Cancer Survivors: A Comprehensive Comparison of Health-Related Outcomes Between Survivors and Individuals Without a History of Cancer. J Cancer Educ 33:214-221

Showing the most recent 10 out of 1193 publications